IP Library Granted Patent US 11,114,195
Granted Patent B2
US 11,114,195 · App. 16/024,141 · Granted Sep 7, 2021

Surgical instrument with a tissue marking assembly

Inventors: Frederick E. Shelton, IV (Hillsboro, OH); David C. Yates (West Chester, OH); Kevin L. Houser (Springboro, OH)
Assignee: Cilag GmbH International
G16H40/20A61B17/072A61B17/07207A61B17/320016A61B17/320092A61B18/1442A61B34/30A61B34/37A61B90/39G16H40/40G16H40/60H04L29/08H04L41/0816H04L67/1097H04L67/12H04W4/33H04W4/38H04W84/20A61B1/00009A61B17/00A61B17/320068A61B18/1206A61B18/14A61B18/1445A61B34/74A61B90/30A61B90/361A61B90/37A61B2017/00017A61B2017/00022A61B2017/00026A61B2017/0046A61B2017/00115A61B2017/00398A61B2017/00734A61B2017/07257A61B2017/07271A61B2017/07285A61B2017/2927A61B2017/32007A61B2018/0063A61B2018/00601A61B2018/00642A61B2018/00994A61B2018/126A61B2018/1253A61B2018/1273A61B2034/2055A61B2034/2063A61B2034/302A61B2090/061A61B2090/064A61B2090/0803A61B2090/395A61B2090/397A61B2090/3908A61B2090/3937A61B2090/3941A61B2090/3987A61B2218/002A61B2218/006A61B2218/007A61B2218/008G16H40/63
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,114,195
App. No.
16/024,141
Filed
Jun 29, 2018
Granted
Sep 7, 2021
Kind
B2
Art Unit
3794
USPC
606/41
Abstract

A surgical instrument includes an end effector and a marking assembly. The end effector includes a first jaw; a second jaw movable relative to the first jaw to grasp tissue therebetween; and a tissue-treatment mechanism configured to apply a tissue treatment to tissue grasped between the first jaw and the second jaw. The marking assembly configured to apply a distinct marking to the tissue unique to each tissue treatment application, wherein the distinct marking distinguishes the tissue treatment application from other tissue treatment applications.

Claims (42)

1. A surgical instrument, comprising:

an end effector, comprising:

a first jaw;

a second jaw movable relative to the first jaw to grasp tissue therebetween; and

a tissue-treatment mechanism configured to apply a tissue treatment to tissue grasped between the first jaw and the second jaw; and

a marking assembly comprising individually manipulatable markers configured to apply a predetermined distinct marking to the tissue unique to each tissue treatment application, wherein the predetermined distinct marking distinguishes the tissue treatment application from other tissue treatment applications.

2. The surgical instrument of claim 1 , wherein the end effector includes a cutting member configured to transect tissue, and wherein the marking assembly is configured to create the predetermined distinct marking adjacent a transection line defined in the tissue by the cutting member.

3. The surgical instrument of claim 1 , wherein the predetermined distinct marking is visible only in the presence of a light source outside of the visible spectrum.

4. The surgical instrument of claim 1 , wherein the predetermined distinct marking is configured to fluoresce under an applied light source outside of the visible spectrum.

5. The surgical instrument of claim 1 , wherein the predetermined distinct marking is detectable through stimulation by at least one of a light source, a radiation source, and an illumination source.

6. The surgical instrument of claim 1 , wherein the tissue-treatment mechanism comprises a staple cartridge configured to deploy staples into the tissue in the tissue treatment application.

7. The surgical instrument of claim 1 , wherein the tissue-treatment mechanism comprises an electrode configured to deliver therapeutic energy to the tissue in the tissue treatment application.

8. The surgical instrument of claim 1 , wherein the tissue-treatment mechanism comprises a transection member movable to transect the tissue in the tissue treatment application.

9. The surgical instrument of claim 1 , wherein application of the tissue treatment by the tissue-treatment mechanism triggers application of the predetermined distinct marking to the tissue by the marking assembly.

10. The surgical instrument of claim 1 , wherein the marking assembly comprises a plurality of spaced apart applicators comprising the individually manipulatable markers.

11. The surgical instrument of claim 10 , wherein the plurality of spaced apart applicators comprises:

a proximal applicator; and

a distal applicator.

12. The surgical instrument of claim 10 , wherein the end effector comprises a longitudinal slot, and wherein the plurality of spaced apart applicators comprises:

a first applicator on a first side of the longitudinal slot; and

a second applicator on a second side of the longitudinal slot opposite the first side.

13. A surgical instrument, comprising:

an end effector, comprising:

a first jaw;

a second jaw movable relative to the first jaw to grasp tissue therebetween; and

a tissue-treatment mechanism configured to apply a tissue treatment to tissue grasped between the first jaw and the second jaw;

a marking assembly; and

a control circuit configured to:

receive sensor signals indicative of application of the tissue treatment to the tissue; and

manipulate the marking assembly to apply a predetermined distinct marking to the tissue unique to the tissue treatment application, wherein the predetermined distinct marking distinguishes the tissue treatment application from other tissue treatment applications.

14. The surgical instrument of claim 13 , wherein the end effector includes a cutting member configured to transect tissue, and wherein the marking assembly is configured to create the predetermined distinct marking adjacent a transection line defined in the tissue by the cutting member.

15. The surgical instrument of claim 13 , wherein the predetermined distinct marking is visible only in the presence of a light source outside of the visible spectrum.

16. The surgical instrument of claim 13 , wherein the predetermined distinct marking is configured to fluoresce under an applied light source outside of the visible spectrum.

17. The surgical instrument of claim 13 , wherein the predetermined distinct marking is detectable through stimulation by at least one of a light source, a radiation source, and an illumination source.

18. The surgical instrument of claim 13 , wherein application of the tissue treatment by the tissue-treatment mechanism triggers application of the distinct marking to the tissue by the marking assembly.

19. The surgical instrument of claim 13 , wherein the marking assembly comprises a plurality of spaced apart applicators.

20. A surgical instrument, comprising:

an end effector, comprising:

a first jaw;

a second jaw movable relative to the first jaw to grasp tissue therebetween; and

a tissue-treatment mechanism configured to apply a tissue treatment to tissue grasped between the first jaw and the second jaw; and

a marker; and means for adjusting the marker to apply a predetermined distinct marking to the tissue unique to each tissue treatment application, wherein the predetermined distinct marking distinguishes the tissue treatment application from other tissue treatment applications.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2021
From: ETHICON LLC
To: CILAG GMBH INTERNATIONAL
Reel/Frame 056601/0339 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2018
From: SHELTON, FREDERICK E., IV; YATES, DAVID C.; HOUSER, KEVIN L.
To: ETHICON LLC
Reel/Frame 046549/0757 →
Cited By (30)
US 12,193,636 US 12,193,766 US 12,226,070 US 12,226,151 US 12,226,166 US 12,239,320 US 12,256,995 US 12,285,185 US 12,290,231 US 12,295,639 US 12,295,674 US 12,303,159 US 12,310,586 US 12,318,152 US 12,329,467 US 12,381,936 US 12,383,115 US 12,396,806 US 12,433,508 US 12,500,948 US 12,514,584 US 12,521,191 US 12,549,622 US 12,574,434 US 12,575,831 US 12,582,457 US 12,648,789 US 12,672,765 US 12,672,922 US 12,708,427